| F.M. Scherer
Health & Pharmaceuticals
In this Working Paper, AAI Senior Fellow F.M. Scherer examines various reasons advanced for the current shortage of flu vaccine in the U.S., finding that multiple sourcing with excess capacity built-in would yield more benefits than it costs.
Click here to view.